EileenAmyRyanMD(She/Her)

PubMed

• 72 citations
  CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a ra...
  Jeffrey E. Lancet, Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Dale L. B...> ;The Lancet. Haematology. 2021 Jul 1
• 11 citations
  Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: Phase 3 post hoc analyses
  Tara L. Lin, David A. Rizzieri, Daniel H. Ryan, Gary J. Schiller, Jonathan E. Kolitz, Geoffrey L. Uy, Donna E. Hogge, Scott R. Solomon, Matthew J. Wieduwilt, Robert J....> ;Blood Advances. 2021 Mar 23
• 17 citations
  Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing ...
  Rebabonye B. Pharithi, Deepti Ranganathan, James O’Brien, Emmanuel E. Egom, Cathie Burke, Daniel H. Ryan, Christine McAuliffe, Marguerite Vaughan, Tara Coughlan, Edwin...> ;Irish Journal of Medical Science. 2019 Feb 1
• Corrigendum: A Hospital Wide Point Prevalence of Adult Urinary Incontinence and Audit of Continence Care.
  Patricia Harkins, Helen O’Brien, Deirdre McCartan, Nizrull Nasir, Billy Twomey, Karthika Srikumar, Tara Coughlan, Sean Kennelly, Paul McElwaine, Desmond O'Neill, Danie...> ;Age and Ageing. 2019 Jan 22
• A multicenter report on the natural history of myelodysplastic syndromes in very old patients (aged over 85 years).
  Laura S McDonald, Peter McCarthy, Mohammad Khan, Patrick Hogan, Eileen Kelleher, Philip Murphy, John Quinn, Ronan Desmond, John McHugh, Melanie Strickland, Elizabeth O...> ;Leukemia & Lymphoma. 2019 Jan 11
• 558 citations
  CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute My...
  Jeffrey E. Lancet, Geoffrey L. Uy, Jorge E. Cortes, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. S...> ;Journal of Clinical Oncology. 2018 Jul 19
• 3 citations
  PKK deficiency in B cells prevents lupus development in Sle lupus mice
  David Oleksyn, Jiyong Zhao, A. Vosoughi, J.C. Zhao, Ravi S. Misra, Alice P. Pentland, Daniel H. Ryan, Jennifer H. Anolik, Christopher T. Ritchlin, J. Looney, Allen P A...> ;Immunology Letters. 2017 May 1
• 2 citations
  Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and...
  James P. Corsetti, Peter Salzman, Daniel H. Ryan, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks> ;Data in Brief. 2016 Sep 1
• 9 citations
  Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation
  James P. Corsetti, Peter Salzman, Daniel H. Ryan, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks> ;Atherosclerosis. 2016 Jul 1
• 4 citations
  A critical role for the protein kinase PKK in the maintenance of recirculating mature B cells and the development of B1 cells.
  Luojing Chen, David Oleksyn, Mary Pulvino, Ignacio Sanz, Daniel H. Ryan, Charlotte K. Ryan, Chyuan-sheng Lin, Brian Poligone, Alice P. Pentland, Christopher T. Ritchli...> ;Immunology Letters. 2016 Apr 1
• 18 citations
  Improving Clinical Practice Guidelines for Practicing Cardiologists
  Jesaia Benhorin, Monty M. Bodenheimer, Mary W. Brown, Robert B. Case, Edward M. Dwyer, Shirley Eberly, Charles W. Francis, John A. Gillespie, Robert E. Goldstein, Henr...> ;The American Journal of Cardiology. 2015 Jun 15
• 3 citations
  Insulin resistance predicts the risk for recurrent coronary events in post-infarction patients
  Barbara Szepietowska, Scott McNitt, Valentina Kutyifa, Daniel H. Ryan, James P. Corsetti, Charles E. Sparks, Arthur J. Moss, Wojciech Zareba> ;Cardiology Journal. 2015 Jan 1
• 20 citations
  Protein kinase C-associated kinase regulates NF-κB activation through inducing IKK activation.
  Sang-Woo Kim, Matthew Schifano, David Oleksyn, Craig T. Jordan, Daniel H. Ryan, Richard A. Insel, Jiyong Zhao, Luojing Chen> ;International Journal of Oncology. 2014 Oct 1
• 4 citations
  Ganglionitis and genetic cardiac arrhythmias: more questions than answers.
  Arthur J. Moss, Daniel H. Ryan, Gabrielle A. Yeaney> ;Circulation. Arrhythmia and Electrophysiology. 2014 Apr 1
• 11 citations
  Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.
  James P. Corsetti, Peter Salzman, Daniel H. Ryan, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks> ;Plos One. 2013 Jul 9
• 9 citations
  Senior Academic Physicians and Retirement Considerations
  Arthur J. Moss, Henry Greenberg, Edward M. Dwyer, Helmut U. Klein, Daniel H. Ryan, Charles W. Francis, Frank I. Marcus, Shirley Eberly, Jesaia Benhorin, Monty M. Boden...> ;Progress in Cardiovascular Diseases. 2013 May 1
• 60 citations
  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review
  Michael J. Rauh, Fazlur Rahman, David Good, Jeffrey A. Silverman, Michael K. Brennan, Nikolay Dimov, Jane L. Liesveld, Daniel H. Ryan, W. Richard Burack, John M. Bennett> ;Leukemia Research. 2012 Jan 1
• Glycerol as a reference material for fecal fat quantitation using low-resolution time domain ¹H NMR spectroscopy.
  James P. Corsetti, Judy Sterry, Manisha Sakpal, Brian H. LeFevre, Daniel H. Ryan> ;Clinical Biochemistry. 2011 Nov 1
• 19 citations
  Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels
  James P. Corsetti, Daniel H. Ryan, Arthur J. Moss, Jeanette J. McCarthy, Ilan Goldenberg, Wojciech Zareba, Charles E. Sparks> ;Thrombosis and Haemostasis. 2011 Oct 20
• 15 citations
  Collaborative Clinical Trials
  Arthur J. Moss, Charles W. Francis, Daniel H. Ryan> ;The New England Journal of Medicine. 2011 Mar 2
• 35 citations
  Cholesteryl Ester Transfer Protein Polymorphism (TaqIB) Associates With Risk in Postinfarction Patients With High C-Reactive Protein and High-Density Lipoprotein Chole...
  James P. Corsetti, Daniel H. Ryan, David L. Rainwater, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2010 Aug 1
• 3 citations
  The common apolipoprotein A-1 polymorphism −75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction
  Robert C. Block, James P. Corsetti, Ilan Goldenberg, Gabriel Vorobiof, Scott McNitt, Daniel H. Ryan, Wojciech Zareba, Arthur J. Moss> ;Heart International. 2009 Jun 30
• 7 citations
  Lp(a) and risk of recurrent cardiac events in obese postinfarction patients
  James P. Corsetti, Daniel H. Ryan, David L. Rainwater, Arthur J. Moss, Wojciech Zareba, Robert C. Block, Charles E. Sparks> ;Obesity. 2008 Dec 1
• 13 citations
  Plasminogen Activator Inhibitor-1 Polymorphism (4G/5G) Predicts Recurrence in Nonhyperlipidemic Postinfarction Patients
  James P. Corsetti, Daniel H. Ryan, Arthur J. Moss, David L. Rainwater, Wojciech Zareba, Charles E. Sparks> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2008 Mar 1
• 23 citations
  NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients.
  James P. Corsetti, Daniel H. Ryan, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks> ;Atherosclerosis. 2008 Jan 1
• Join now to see all

Abstracts/Posters

• Phase 3 Exploratory Analysis of Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Received Consolidation with CPX-351 ...
  Daniel H. Ryan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (AML) with Prior Hypomethylatin...
  Daniel H. Ryan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Anal... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019